Protein Diagnostics Market Size, Share, Trends & Forecast
The Protein Diagnostics Market is expanding as healthcare providers and research organizations place greater emphasis on accurate disease detection, biomarker analysis, and personalized medicine. According to WiseGuyReports, the market was valued at USD 9.3 billion in 2025 and is projected to reach USD 15 billion by 2035, representing a CAGR of 4.9% during the forecast period.
The increasing prevalence of chronic diseases is an important factor supporting demand. Conditions such as cancer and cardiovascular disorders require reliable diagnostic approaches capable of identifying relevant biological indicators. Protein-based diagnostics can contribute to this process by examining proteins and biomarkers associated with different disease states.
Clinical diagnostics represents a major application area. The segment was valued at approximately USD 4 billion in 2024 and is projected to reach USD 6 billion by 2035. Demand is being supported by improvements in diagnostic technologies and the continued need for earlier and more precise disease identification.
Personalized medicine is creating another avenue for market development. As healthcare moves toward treatment strategies tailored to individual patient characteristics, protein biomarkers can provide valuable information for disease characterization and treatment-related decision-making.
Pharmaceutical companies are also contributing to market expansion through drug discovery and development activities. Protein diagnostics can support biomarker identification and research into potential therapeutic targets, strengthening the connection between diagnostics and pharmaceutical innovation.
Going forward, the market is expected to benefit from advances in laboratory automation, artificial intelligence, high-throughput testing, and point-of-care technologies. These developments can improve testing efficiency while expanding the role of protein diagnostics across clinical and research environments.